Endoglin modulation of TGF-β1-induced collagen synthesis is dependent on ERK1/2 MAPK activation

Cellular Physiology and Biochemistry

Volumn 18, Issue 1-3, 2006, Pages 135-142

  Rodríguez Barbero, Alicia ^a   Obreo, Juana ^a   Álvarez Muñoz, Patricia ^a   Pandiella, Atanasio ^b   Bernabéu, Carmelo ^c   López Novoa, José M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b CSIC   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Collagen; Endoglin; ERK1 2; Extracellular matrix (ECM); L6E9 myoblasts; p38; TGF receptor system; Transforming growth factor beta (TGF )

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN; ENDOGLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROLINE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROSIS; GENETIC TRANSFECTION; MYOBLAST; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SYNTHESIS; WESTERN BLOTTING;

EID: 33747356702     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095181     Document Type: Article

References (35)

1. Border WA, Okuda S, Languino LR. Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990;346:371-374.
2. Roberts AB, Sporn M.B: Physiological actions and clinical applications of transforming growth factor- β (TGF- β). Growth Factors 1993;8:1-9.
3. Raines E, Ross R: Mechanisms of plaque formation. Cellular changes and the possible role of growth-regulatory molecules. Atheroscl Rev 1991;23:143-152.
4. Rojkind M: From regeneration to scar formation: the collagen way. Lab Invest 1991;64:131-134.
5. Javelaud D, Mauviel A: Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol 2004;36:1161-1165.
6. Cheifetz S, Bellón T, Calés C, Vera S, Bernabéu C, Massagué J, Letarte M: Endoglin is a component of the transforming growth factor- β receptor system in human endothelial cells. J Biol Chem 1992;267:19027-19030.
7. Letamendía A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C: Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with betaglycan, J Biol Chem 1998;273:33011-33019.
8. Barbara NP, Wrana JL, Letarte M: Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the TGF β superfamily. J Biol Chem 1999;274:584-594.
9. Lastres P, Letamendia A, Zhang H, Rius C, Almendro C, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu M: Endoglin modulates cellular responses to TGF- β1. J Cell Biol 1996;133:1109-1121.
10. Rodriguez-Peña A, Prieto M, Duwel A, Rivas JV, Eleno N, Perez-Barriocanal F, Arevalo M, Smith JD, Vary CP, Bernabeu C, Lopez-Novoa JM: Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction. Nephrol Dial Transplant 2001;16:34-39.
11. Rodriguez-Peña A, Eleno N, Duwell A, Arévalo M, Perez-Barriocanal F, Flores O, Docherty N, Bernabeu C, Letarte M, López-Novoa JM: Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 2002;4:713-720.
12. Rodríguez-Barbero A, Obreo J, Eleno N, Rodríguez-Peña A, Düwel A, Jerkic M, Sánchez-Rodríguez A, Bernabéu C, López-Novoa JM: Endoglin expression in human and rat mesangial cells an its upregulation by TGF-β1. Biochem Biophys Res Com 2001;23:142-147.
13. Díez-Marques L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa JM, Lamas S, Bernabeu C: Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis. Biochem Biophys Acta 2002;158:36-44.
14. Obreo J, Diez-Marques L, Lamas S, Duwell A, Eleno N, Bernabeu C, Pandiella A, Lopez-Novoa JM, Rodriguez-Barbero A: Endoglin expression regulates basal and TGF-betal-induced extracellular matrix synthesis in cultured L6E9 myoblasts. Cell Physiol Biochem 2004;14:301-310.
15. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584.
16. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 1995;9:726-35.
17. Treisman R: Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996;8:205-215.
18. Sugden PH, Clerk A: Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 1997;9:337-351.
19. Paul A, Wilson S, Belham CM, Robinson CMJ, Scott PH, Gould GW, Plevin R: Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997;9:403-410.
20. Huwiler A, Pfeilschifter J: Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells. FEBS Lett 1994;14:255-258.
21. Mulder KM, Morris SL: Activation of p21ras by transforming growth factor beta in epithelial cells. J Biol Chem 1992;267:5029-5031.
22. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995;270:2008-2011.
23. Yan Z, Winawer S, Friedman E: Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. J Biol Chem 1994;269:13231-13237.
24. Frey RS, Mulder KM: Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 1997;57:628-633.
25. Rodriguez-Barbero A, Obreo J, Yuste L, Montero JC, Rodriguez-Pena A, Pandiella A, Bernabeu C, Lopez-Novoa JM: Transforming growth factor-beta 1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett 2002;513:282-288.
26. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K: p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003;38:879-889.
27. Ignotz RA, Endo T, Massague J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987;262:6443-6446.
28. Heino J, MassagueJ: Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta. J Biol Chem 1990;265:10181-10184.
29. Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S: CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res 2004;24:1337-1345.
30. Guo G, Rooney P, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S: Overexpression of CD105 in rat myoblasts: role of CD105 in cell attachment, spreading and survival. Int J Oncol 2004;25:285-291.
31. Jerkic M, Rivas-Elena JV, Prieto M, Carron R, Sanz-Rodriguez F, Perez-Barriocanal F, Rodriguez-Barbero A, Bernabeu C, Lopez-Novoa JM: Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004;18:609-611.
32. Botella LM, Sanz-Rodriguez F, Sanchez-Elsner T, Langa C, Ramirez JR, Vary C, Roughley PJ, Bernabeu C: Lumican is down-regulated in cells expressing endoglin. Evidence for an inverse correlationship between Endoglin and Lumican expression. Matrix Biol 2004;22:561-572.
33. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;3:169-178.
34. Hayashida T, Decaestecker M, Schnaper HW: Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 2003;17:1576-1578.
35. Tiffin N, Adi S, Stokoe D, Wu NY, Rosenthal SM: Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology 2004;145:4991-4996.